Taking 0.15 mg of nonivamide daily may reduce body fat and raise serotonin levels in people who are moderately overweight, but only if their diet is controlled and only for a short time. These...

We analyzed one assertion about 0.15 mg of nonivamide daily in moderately overweight adults on a controlled diet, and it is the only piece of evidence we have reviewed so far. This single assertion suggests that, under those specific conditions — moderate overweight, controlled diet, and short-term use — nonivamide may be linked to a reduction in body fat and a rise in serotonin levels. It also notes that these changes do not appear in people who are lean or obese, or when the supplement is taken for longer periods [1]. We have no studies that contradict this claim, but we also have no additional research to confirm, expand, or challenge it. The evidence we’ve reviewed is limited to just one assertion, and it does not describe how serotonin was measured, how body fat was tracked, or how long “short time” actually means. There is no data on whether the effects are meaningful for health, or if they return once use stops. Because we only have one source, and it does not come from a published study with methods or numbers, we cannot say whether this is reliable or repeatable. The claim is specific — it only applies to a narrow group under strict conditions — and we have no way to know if other factors, like sleep, stress, or activity levels, played a role. What we’ve found so far is not enough to draw a clear picture. The evidence leans toward the possibility of an effect in this exact scenario, but without more data, we can’t say how strong, lasting, or real that effect might be. If you’re considering nonivamide, know that this is based on one unverified claim under very specific conditions. It’s not a proven tool for fat loss or mood support, and we don’t yet know if it works beyond those narrow limits.